In this issue:
Soluble CD105 as a noninvasive measure of LV filling pressure
Surgical weight loss and NT-proBNP levels
Spironolactone and LV function in early-stage CKD
Outcomes with early collaborative heart failure care after ED discharge
Coffee consumption and heart failure risk
LV dysfunction with cardiotoxic cancer therapies
PRIMA & SIGNAL-HF: NT-proBNP-guided therapy for heart failure
GISSI-HF substudy: n-3 PUFAs/rosuvastatin and LV function in chronic heart failure
Metformin and mortality risk in diabetes with heart failure
Telemonitoring in heart failure
Please login below to download this issue (PDF)